VisionGate Focuses on the Importance of Early Detection During Lung Cancer Awareness Month
Staying Informed and Knowing Early Detection Options Can Keep You and Your Family Living Well
For many families, November signals the start of the holiday season. It is a special time to gather with loved ones and check-in to make sure everyone is happy and healthy. November is also lung cancer awareness month.
VisionGate wants to help you, your family and loved ones learn more about who is at risk, the impact, and the types of lung cancer. Because keeping yourself informed about the risks and early detection options can provide comfort now through holidays and into the future.
It’s Not Just Smokers Who Are At Risk of Lung Cancer
Lung cancer affects hundreds of thousands of people every year, with a low survival rate due to late detection. In fact, Lung Cancer takes more lives annually in the United States than the next three most common cancers combined. Only 19% of people diagnosed with lung cancer expect to survive for five years or more, but if caught early, chances of a 5-year survival rate improve dramatically.
Understanding your risk factors can help you take advantage of early detection options. Heavy smokers are high risk patients, but there are also several other factors that may increase your risk of Lung Cancer, such as family history, emphysema and COPD.
Current lung cancer detection methods rely on a CT scan (LDCT) and are often only offered to high-risk patients or those who are symptomatic. Unfortunately, if you have symptoms of lung cancer, it is more likely to be a later stage.
It is important to be aware of the risks and start talking to your doctor early, even before any symptoms start to show.
Together, through Early Detection, We Can Save Lives
There are several kinds of lung cancer based on the tissue and placement inside the lung in early stage. Detecting these early forms at a cellular level is critical.
Extensive clinical studies have shown that the earliest stages of lung cancer is not easily detected through blood. Early stage cancer is similar to a wart on the lining of the lung walls that can be detected on a cellular level. VisionGate’s LuCED test does not rely on a blood draw. Instead, we use a non-intrusive sputum sample, collected through a deep cough.
With our simple test, we are dedicated to saving lives by catching lung cancer before it’s too late. Our early detection technology works together to three-dimensionally examine your cells and identify abnormal cells.
